BIOMAT Database Logo BIOMAT Database Logo

Preparation and Evaluation of PEGylated Poly-L-ornithine Complex as a Novel Absorption Enhancer. 2017

Yusuke Kamiya, and Tsutomu Yamaki, and Masaki Uchida, and Tomomi Hatanaka, and Mitsutoshi Kimura, and Masahiko Ogihara, and Yasunori Morimoto, and Hideshi Natsume
Faculty of Pharmaceutical Sciences, Josai University.

Polycationic compounds, such as poly-L-arginine and poly-L-ornithine (PLO), enhance the nasal absorption of hydrophilic macromolecular drugs. However, the bio availability corresponding to the dose of these enhancers has not been obtained in an open system study, where an administered solution is transferred to the pharynx because they do not exhibit mucoadhesion/retention in the nasal cavity. In this study, we prepared PEGylated-poly-L-ornithine (PEG-PLO) and investigated the effects of PEGylation on in vitro adhesion/retention properties, permeation enhancement efficiency, and cytotoxicity. PEG-PLO bearing 3-4 polyethylene glycol (PEG) chains per PLO molecule was more retentive than unmodified PLO on an inclined plate. The permeability of a model drug, FD-4, across Caco-2 cell sheets was enhanced by PEG-PLO as well as by PLO. PLO showed cytotoxicity at high concentrations, whereas PEG-PLO did not decrease cell viability, even above the concentration giving a sufficient enhancement effect. These findings suggest that PEGylation of polycationic absorption enhancers improves their adhesion/retention and decreases their cytotoxicity, which may lead to enhancers with greater utility.

UI MeSH Term Description Entries
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013501 Surface-Active Agents Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. Surface Active Agent,Surface-Active Agent,Surfactant,Surfactants,Tenside,Amphiphilic Agents,Surface Active Agents,Tensides,Active Agent, Surface,Active Agents, Surface,Agent, Surface Active,Agent, Surface-Active,Agents, Amphiphilic,Agents, Surface Active,Agents, Surface-Active
D018938 Caco-2 Cells Human colonic ADENOCARCINOMA cells that are able to express differentiation features characteristic of mature intestinal cells, such as ENTEROCYTES. These cells are valuable in vitro tools for studies related to intestinal cell function and differentiation. Caco 2 Cells,Caco-2 Cell,Cell, Caco-2,Cells, Caco-2
D065569 Gastrointestinal Absorption Uptake of substances via the GASTROINTESTINAL TRACT. Gut Absorption,Absorption, Gastrointestinal,Absorption, Gut

Related Publications

Yusuke Kamiya, and Tsutomu Yamaki, and Masaki Uchida, and Tomomi Hatanaka, and Mitsutoshi Kimura, and Masahiko Ogihara, and Yasunori Morimoto, and Hideshi Natsume
Ferric complexes of acetoacetyl derivatives of poly(L-lysine), poly(L-ornithine), and poly(L-diaminobutyric acid). I. Preparation and absorption properties in solution.
November 1976, Biopolymers,
Yusuke Kamiya, and Tsutomu Yamaki, and Masaki Uchida, and Tomomi Hatanaka, and Mitsutoshi Kimura, and Masahiko Ogihara, and Yasunori Morimoto, and Hideshi Natsume
Evaluation and mechanism studies of PEGylated dendrigraft poly-L-lysines as novel gene delivery vectors.
July 2010, Nanotechnology,
Yusuke Kamiya, and Tsutomu Yamaki, and Masaki Uchida, and Tomomi Hatanaka, and Mitsutoshi Kimura, and Masahiko Ogihara, and Yasunori Morimoto, and Hideshi Natsume
Poly (delta-L-ornithine).
February 1981, International journal of peptide and protein research,
Yusuke Kamiya, and Tsutomu Yamaki, and Masaki Uchida, and Tomomi Hatanaka, and Mitsutoshi Kimura, and Masahiko Ogihara, and Yasunori Morimoto, and Hideshi Natsume
Evaluation of cytotoxicity and absorption enhancing effects of melittin - a novel absorption enhancer.
July 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,
Yusuke Kamiya, and Tsutomu Yamaki, and Masaki Uchida, and Tomomi Hatanaka, and Mitsutoshi Kimura, and Masahiko Ogihara, and Yasunori Morimoto, and Hideshi Natsume
Preparation and analysis of PEGylated poly-L-lysine DNA nanoparticles for gene delivery.
May 2010, Cold Spring Harbor protocols,
Yusuke Kamiya, and Tsutomu Yamaki, and Masaki Uchida, and Tomomi Hatanaka, and Mitsutoshi Kimura, and Masahiko Ogihara, and Yasunori Morimoto, and Hideshi Natsume
[Industrial preparation of L-ornithine].
July 1966, Il Farmaco; edizione pratica,
Yusuke Kamiya, and Tsutomu Yamaki, and Masaki Uchida, and Tomomi Hatanaka, and Mitsutoshi Kimura, and Masahiko Ogihara, and Yasunori Morimoto, and Hideshi Natsume
Controllable fabrication of alginate/poly-L-ornithine polyelectrolyte complex hydrogel networks as therapeutic drug and cell carriers.
January 2022, Acta biomaterialia,
Yusuke Kamiya, and Tsutomu Yamaki, and Masaki Uchida, and Tomomi Hatanaka, and Mitsutoshi Kimura, and Masahiko Ogihara, and Yasunori Morimoto, and Hideshi Natsume
Comparison of helix stabilities of poly-L-lysine, poly-L-ornithine, and poly (L-diaminobutyric acid).
January 1971, Biopolymers,
Yusuke Kamiya, and Tsutomu Yamaki, and Masaki Uchida, and Tomomi Hatanaka, and Mitsutoshi Kimura, and Masahiko Ogihara, and Yasunori Morimoto, and Hideshi Natsume
Ferric complexes of acetoacetyl derivatives of poly(L-lysine), poly(L-ornithine), and poly(L-diaminobutyric acid). II. Conformational properties in solution. Evidence for a stereospecific complex formation.
November 1976, Biopolymers,
Yusuke Kamiya, and Tsutomu Yamaki, and Masaki Uchida, and Tomomi Hatanaka, and Mitsutoshi Kimura, and Masahiko Ogihara, and Yasunori Morimoto, and Hideshi Natsume
Epidermal growth factor labeled beta-amanitin-poly-L-ornithine: preparation and evidence for specific cytotoxicity.
July 1990, Biochemistry,
Copied contents to your clipboard!